These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 28595180)

  • 1. Fibrotic Changes Mediating Acute Kidney Injury to Chronic Kidney Disease Transition.
    Ó hAinmhire E; Humphreys BD
    Nephron; 2017; 137(4):264-267. PubMed ID: 28595180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Kidney Injury: Tubular Markers and Risk for Chronic Kidney Disease and End-Stage Kidney Failure.
    Tan HL; Yap JQ; Qian Q
    Blood Purif; 2016; 41(1-3):144-50. PubMed ID: 26764483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute Kidney Injury to Chronic Kidney Disease Transition.
    Fiorentino M; Grandaliano G; Gesualdo L; Castellano G
    Contrib Nephrol; 2018; 193():45-54. PubMed ID: 29393158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rodent models of AKI-CKD transition.
    Fu Y; Tang C; Cai J; Chen G; Zhang D; Dong Z
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1098-F1106. PubMed ID: 29949392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic Changes in the Acute Kidney Injury-to-Chronic Kidney Disease Transition.
    Nangaku M; Hirakawa Y; Mimura I; Inagi R; Tanaka T
    Nephron; 2017; 137(4):256-259. PubMed ID: 28595179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent effects of AKI to CKD models on inflammation and fibrosis.
    Black LM; Lever JM; Traylor AM; Chen B; Yang Z; Esman SK; Jiang Y; Cutter GR; Boddu R; George JF; Agarwal A
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1107-F1118. PubMed ID: 29897282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unilateral Renal Ischemia-Reperfusion as a Robust Model for Acute to Chronic Kidney Injury in Mice.
    Le Clef N; Verhulst A; D'Haese PC; Vervaet BA
    PLoS One; 2016; 11(3):e0152153. PubMed ID: 27007127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia as a key player in the AKI-to-CKD transition.
    Tanaka S; Tanaka T; Nangaku M
    Am J Physiol Renal Physiol; 2014 Dec; 307(11):F1187-95. PubMed ID: 25350978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of Chronic Kidney Disease After Acute Kidney Injury: Role of Self-Perpetuating Versus Hemodynamic-Induced Fibrosis.
    Picken M; Long J; Williamson GA; Polichnowski AJ
    Hypertension; 2016 Oct; 68(4):921-8. PubMed ID: 27550923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How Acute Kidney Injury Contributes to Renal Fibrosis.
    Yang L
    Adv Exp Med Biol; 2019; 1165():117-142. PubMed ID: 31399964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the Mechanisms of the Acute Kidney Injury-to-Chronic Kidney Disease Continuum.
    Takaori K; Yanagita M
    Nephron; 2016; 134(3):172-176. PubMed ID: 27398799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AKI: an increasingly recognized risk factor for CKD development and progression.
    Kurzhagen JT; Dellepiane S; Cantaluppi V; Rabb H
    J Nephrol; 2020 Dec; 33(6):1171-1187. PubMed ID: 32651850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of multiple episodes of acute kidney injury on survival and progression to end stage kidney disease in patients with chronic kidney disease.
    Sykes L; Asar O; Ritchie J; Raman M; Vassallo D; Alderson HV; O'Donoghue DJ; Green D; Diggle PJ; Kalra PA
    PLoS One; 2019; 14(7):e0219828. PubMed ID: 31318937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed spironolactone administration prevents the transition from acute kidney injury to chronic kidney disease through improving renal inflammation.
    Barrera-Chimal J; Rocha L; Amador-Martínez I; Pérez-Villalva R; González R; Cortés-González C; Uribe N; Ramírez V; Berman N; Gamba G; Bobadilla NA
    Nephrol Dial Transplant; 2019 May; 34(5):794-801. PubMed ID: 30107561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial dysfunction and the AKI-to-CKD transition.
    Jiang M; Bai M; Lei J; Xie Y; Xu S; Jia Z; Zhang A
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1105-F1116. PubMed ID: 33073587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting the transition of acute kidney injury to chronic kidney disease: Potential mechanisms and future perspectives.
    Ogbadu J; Singh G; Aggarwal D
    Eur J Pharmacol; 2019 Dec; 865():172711. PubMed ID: 31589870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current understanding of the administration of mesenchymal stem cells in acute kidney injury to chronic kidney disease transition: a review with a focus on preclinical models.
    Zhao L; Han F; Wang J; Chen J
    Stem Cell Res Ther; 2019 Dec; 10(1):385. PubMed ID: 31843011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two-stage bilateral ischemia-reperfusion injury-induced AKI to CKD transition model in mice.
    Zhang J; Wang X; Wei J; Wang L; Jiang S; Xu L; Qu L; Yang K; Fu L; Buggs J; Cheng F; Liu R
    Am J Physiol Renal Physiol; 2020 Aug; 319(2):F304-F311. PubMed ID: 32567350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic kidney disease following acute kidney injury-risk and outcomes.
    Leung KC; Tonelli M; James MT
    Nat Rev Nephrol; 2013 Feb; 9(2):77-85. PubMed ID: 23247572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathway from Acute Kidney Injury to Chronic Kidney Disease: Molecules Involved in Renal Fibrosis.
    Niculae A; Gherghina ME; Peride I; Tiglis M; Nechita AM; Checherita IA
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.